Skip to main content

Table 3 The results of both groups (group A, with therapy; group B, without treatment (control group); Q, question, *significant p-value < 0.05)

From: Impact of intralesional botulinum toxin type A therapy on the keloid-related quality of life

 

Group A

Group B

Z-value

p-value

Q1

Item 1

1.3 ± 0.53

5.86 ± 1.563

10.476

 < 0.0001*

Item 2

1.24 ± 0.48

6.42 ± 1.43

10.592

 < 0.0001*

Item 3

1.22 ± 0.84

5.88 ± 1.21

10.603

 < 0.0001*

Item 4

1.18 ± 0.44

5.16 ± 1.16

10.737

 < 0.0001*

Q2

Item 1

1.4 ± 0.74

4.46 ± 0.709

10.327

 < 0.0001*

Item 2

1.3 ± 0.63

4.4 ± 0.593

10.561

 < 0.0001*

Item 3

1.29 ± 0.61

4.42 ± 0.596

10.570

 < 0.0001*

Item 4

1.22 ± 0.56

4.23 ± 0.732

10.623

 < 0.0001*

Q3

1.83 ± 0.79

5.18 ± 0.947

9.977

 < 0.0001*

Q4

2.71 ± 0.83

5.72 ± 0.559

10.16

 < 0.0001*

Q5

2.05 ± 0.89

3.58 ± 1.499

6.11

 < 0.0001*

Q6

2.19 ± 0.8

3.3 ± 1.133

5.802

 < 0.0001*

Q7

2.07 ± 0.82

4.21 ± 1.25

8.249

 < 0.0001*

Q8

1.52 ± 0.78

2.75 ± 1.93

4.353

 < 0.0001*

Q9

2.95 ± 0.71

5.79 ± 0.411

10.385

 < 0.0001*

Q10

1.67 ± 0.6

3.93 ± 0.258

10.514

 < 0.0001*

Q11

1.83 ± 0.67

3.95 ± 0.225

10.393

 < 0.0001*

Q12

1.31 ± 0.58

3.11 ± 0.724

9.591

 < 0.0001*

Q13

1.08 ± 0.54

3.39 ± 0.75

10.195

 < 0.0001*

Q14

1.73 ± 0.54

3.96 ± 0.186

10.685

 < 0.0001*

Q15

1.76 ± 0.53

3.95 ± 0.225

10.687

 < 0.0001*

Subscale 1

10.17 ± 2.38

40.82 ± 2.752

10.126

 < 0.0001*

Subscale 2

7.49 ± 1.37

16.68 ± 1.391

10.104

 < 0.0001*

Subscale 3

10.2 ± 1.62

20.33 ± 2.747

10.071

 < 0.0001*

Subscale 4

7 ± 1.45

15.79 ± 0.453

10.278

 < 0.0001*

Total score

34.87 ± 3.73

93.63 ± 3.862

10.045

 < 0.0001*